Latest Senior Health News
MONDAY, Jan. 4, 2016 (HealthDay News) -- Higher doses of vitamin D don't improve mobility for the elderly, and may actually raise the risk for falls among certain seniors, a new study suggests.
The small Swiss study, published in the Jan. 4 issue of JAMA Internal Medicine, doesn't say that vitamin D is harmful in routine doses. And, the researchers say seniors should continue to follow guidelines and make sure they get recommended amounts of the nutrient naturally.
However, "don't assume that because something is called a 'vitamin' it means that it is safe," cautioned Dr. Steven Cummings, research scientist with California Pacific Medical Center Research Institute in San Francisco.
Cummings is co-author, along with Dr. Douglas Kiel, of a commentary accompanying the study.
Many older adults get too little vitamin D in their diet and don't spend enough time outside to get it through sun exposure, said Kiel, director of musculoskeletal research at the Institute for Aging Research at Hebrew SeniorLife in Boston, and professor of medicine at Harvard Medical School. Low levels are most common in the frailest individuals, he noted.
Inexpensive vitamin D supplements, often recommended for boosting levels of vitamin D, are widely available in the United States.
For the study, the researchers recruited 200 people in Switzerland age 70 and older -- average age 78 -- who'd fallen over the previous year. Two-thirds were female and almost 60 percent had low levels of vitamin D, the researchers said.
Participants were divided into three groups and given a form of the vitamin called D3, which is commonly available via over-the-counter supplements.
One group received the equivalent of 800 International Units (IU) a day. Another group took that dose plus a vitamin D product called calcifediol (also known as calcidiol). The third group consumed the equivalent of 2,000 IU of vitamin D3 a day.
The researchers tracked the participants for a year. They expected to see fewer falls because previous research had shown vitamin D to benefit mobility, said study lead author Dr. Heike Bischoff-Ferrari, chair of geriatrics and aging research at the University of Zurich in Switzerland.
Instead, two-thirds of those taking the higher dose of vitamin D and vitamin D plus calcifediol experienced falls compared to 48 percent of those on the lower dose. The lower-dose group also had the best improvement in leg function among the three groups, the study found.
One explanation, Bischoff-Ferrari said, is that there's an ideal range for vitamin D in seniors who've fallen before, with higher levels possibly translating into more falls. Another possibility, Bischoff-Ferrari said, is that seniors become more physically active when taking higher doses of vitamin D, which puts them at risk of more falls.
Cummings, however, said the theory about increased activity seems unlikely. Kiel, meanwhile, said another possibility is that high doses of vitamin D might disrupt muscle activity, leading to falls that way.
Also, the study doesn't establish a direct cause-and-effect relationship between higher doses of vitamin D and more falls.
Still, if you're healthy and not confined to bed, "there is no evidence that you need or will benefit from any vitamin D supplementation," said Cummings.
"The Institute of Medicine recommended that older adults should get about 800 IU per day, and diet and sun are the best ways to do that," Cummings said. "There is no good evidence yet that taking even 800 IU per day as supplements will reduce your risk of diseases or prolong your mobility or your life."
Kiel agreed. "Until the safety of larger doses of vitamin D is established, it is better to either get enough vitamin D from diet or take more modest daily supplements if there is a deficiency," he said.
Copyright © 2016 HealthDay. All rights reserved.
SOURCES: Heike Bischoff-Ferrari, M.D., Dr.P.H., chair, Department of Geratrics and Aging Research, University Hospital of Zurich and University of Zurich, Switzerland; Douglas Kiel, M.D., M.P.H., director, Musculoskeletal Research Center, and senior scientist, Institute for Aging Research, Hebrew SeniorLife, and professor of medicine, Harvard Medical School, Boston; Steven Cummings, M.D., research scientist, California Pacific Medical Center Research Institute, and emeritus professor of medicine, epidemiology and biostatistics, University of California, San Francisco; Jan. 4, 2016, JAMA Internal Medicine